Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Cystatin C Assay Market to reach USD 625.47 million by the end of 2030.

Global Cystatin C Assay Market Size Study & Forecast, by Product (Analyzers, Kits, Reagents), by Method (ELISA, PETIA, PENIA, CLIA, IFA, Others), by Sample Type (Blood, Urine), by Application (Diagnostics, Research), by End-user (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes), and Regional Analysis, 2023-2030

Product Code: HLSMD-96754157
Publish Date: 20-02-2024
Page: 200

Global Cystatin C Assay Market is valued at approximately USD 350.70 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% during the forecast period 2023-2030. The Cystatin C assay is a diagnostic test that measures the levels of cystatin C in the blood, a protein produced by cells and filtered through the kidneys. Cystatin C is less affected by age and muscle mass compared to conventional kidney function measures. This test is useful for monitoring kidney disorders, determining the glomerular filtration rate, and evaluating renal function. It offers vital information about general renal health and is used by medical practitioners to inform treatment choices and assess the risk of issues connected to the kidneys. The increasing prevalence of kidney diseases, supportive government policies, surge in healthcare expenditure, as well as flourishing growth of the biotechnology and biopharmaceutical industries, are the most prominent factors that are bolstering the market demand across the globe.

Additionally, the growing incidences of chronic kidney diseases are expected to boost the Cystatin C Assay Market. A 2022 report from the Centers for Disease Control and Prevention (CDC) reveals that over 14% of U.S. adults, approximately 37 million individuals, suffer from CKD. Consequently, with the rising prevalence of chronic kidney diseases worldwide, there is an increasing demand for reliable diagnostic solutions to measure cystatin C concentration, thereby propelling market expansion. Also, the growing geriatric population base is further presenting various growth prospects for market expansion as they are more prone to be affected by the CKD and various chronic diseases due to their weak immune system. As per the United Nations, there were 703 million persons aged 65 years or over in the world in 2019. The figure for aged persons is projected to get double and reach 1.5 billion by 2050. Thereby, the demand for cystatin C assays is expected to increase as the growing incidences of chronic kidney diseases, along with the global population age. Moreover, the increasing adoption of point of care testing, as well as the rising focus on the development of condition-specific biomarkers and tests presents various lucrative opportunities over the forecast years. However, the high development costs of cystatin C assays and stringent requirements for approval of cystatin C assay instruments and consumables are hindering market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cystatin C Assay Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the stringent regulatory standards, an increasing trend in healthcare expenditure, the growing prevalence of chronic kidney diseases, the increasing elderly population, and the high presence of manufacturers specializing in cystatin C assays. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The surge in health awareness, escalating healthcare spending, the growth of medical tourism, and the expanding geriatric demographic are significantly propelling the market demand across the region. The rise in the elderly population is associated with a higher incidence of nephros diseases. Consequently, the increase in kidney diseases leading to the expansion of this demographic is directly stimulating the demand for cystatin C assay products. This, in turn, is fostering growing research and development activities and strategic initiatives by key industry players.

Major market players included in this report are:
Abbott (US)
Roche Diagnostics Limited (Switzerland)
Siemens Healthineers AG (Germany)
Thermo Fisher Scientific Inc. (US)
Randox Laboratories Ltd. (UK)
DiaSys Diagnostic Systems GmbH (Germany)
Bio-Techne (US)
Gentian Diagnostics ASA (Norway)
Getein Biotech, Inc. (China)
Agilent Technologies, Inc. (US)

Recent Developments in the Market:
Ø In March 2021, Roche completed the acquisition of GenMark Diagnostics, purchasing each share for USD 24.05 and achieving a total transaction value of USD 1.8 billion. This strategic move significantly bolstered Roche’s Diagnostics portfolio.
Ø In March 2022, Gentian- a leading participant in the cystatin C test industry announced that TüV SÜD has validated their GCAL and Cystatin C assays for IVDR (In-Vitro Diagnostic Regulation). The assays meet the regulatory requirements outlined by IVDR, as indicated by this certification. This strategic introduction aimed to increase income and broaden its services.

Global Cystatin C Assay Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Method, Sample Type, Application, End-user, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

By Method:
Enzyme-Linked Immunosorbent Assay (ELISA)
Particle-Enhanced Turbidimetric Immunoassay (PETIA)
Particle-enhanced Nephelometric Immunoassay (PENIA)
Chemiluminescent immunoassay (CLIA)
Immunofluorescence assay (IFA)

By Sample Type:

By Application:

By End-user:
Clinical Laboratories
Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Cystatin C Assay Market, by Region, 2020-2030 (USD Million)
1.2.2. Cystatin C Assay Market, by Product, 2020-2030 (USD Million)
1.2.3. Cystatin C Assay Market, by Method, 2020-2030 (USD Million)
1.2.4. Cystatin C Assay Market, by Sample Type, 2020-2030 (USD Million)
1.2.5. Cystatin C Assay Market, by Application, 2020-2030 (USD Million)
1.2.6. Cystatin C Assay Market, by End-user, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cystatin C Assay Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cystatin C Assay Market Dynamics
3.1. Cystatin C Assay Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Supportive government policies Rising incidences of chronic kidney diseases and increasing aging population
3.1.2. Market Challenges High development costs of cystatin C assays Stringent requirements for approval of cystatin C assay instruments and consumables
3.1.3. Market Opportunities Increasing adoption of point of care testing Rising focus on the development of condition-specific biomarkers and tests
Chapter 4. Global Cystatin C Assay Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Cystatin C Assay Market, by Product
5.1. Market Snapshot
5.2. Global Cystatin C Assay Market by Product, Performance – Potential Analysis
5.3. Global Cystatin C Assay Market Estimates & Forecasts by Product 2020-2030 (USD Million)
5.4. Cystatin C Assay Market, Sub Segment Analysis
5.4.1. Analyzers
5.4.2. Kits
5.4.3. Reagents
Chapter 6. Global Cystatin C Assay Market, by Method
6.1. Market Snapshot
6.2. Global Cystatin C Assay Market by Method, Performance – Potential Analysis
6.3. Global Cystatin C Assay Market Estimates & Forecasts by Method 2020-2030 (USD Million)
6.4. Cystatin C Assay Market, Sub Segment Analysis
6.4.1. Enzyme-Linked Immunosorbent Assay (ELISA)
6.4.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
6.4.3. Particle-enhanced Nephelometric Immunoassay (PENIA)
6.4.4. Chemiluminescent immunoassay (CLIA)
6.4.5. Immunofluorescence assay (IFA)
6.4.6. Others
Chapter 7. Global Cystatin C Assay Market, by Sample Type
7.1. Market Snapshot
7.2. Global Cystatin C Assay Market by Sample Type, Performance – Potential Analysis
7.3. Global Cystatin C Assay Market Estimates & Forecasts by Sample Type 2020-2030 (USD Million)
7.4. Cystatin C Assay Market, Sub Segment Analysis
7.4.1. Blood
7.4.2. Urine
Chapter 8. Global Cystatin C Assay Market, by Application
8.1. Market Snapshot
8.2. Global Cystatin C Assay Market by Application, Performance – Potential Analysis
8.3. Global Cystatin C Assay Market Estimates & Forecasts by Application 2020-2030 (USD Million)
8.4. Cystatin C Assay Market, Sub Segment Analysis
8.4.1. Diagnostics
8.4.2. Research
Chapter 9. Cystatin C Assay Market, by End-user
9.1. Market Snapshot
9.2. Global Cystatin C Assay Market by End-user, Performance – Potential Analysis
9.3. Global Cystatin C Assay Market Estimates & Forecasts by End-user 2020-2030 (USD Million)
9.4. Cystatin C Assay Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Clinical Laboratories
9.4.3. Pharmaceutical and Biotechnology Companies & CROs & Academic research institutes
Chapter 10. Global Cystatin C Assay Market, Regional Analysis
10.1. Top Leading Countries
10.2. Top Emerging Countries
10.3. Cystatin C Assay Market, Regional Market Snapshot
10.4. North America Cystatin C Assay Market
10.4.1. U.S. Cystatin C Assay Market Product breakdown estimates & forecasts, 2020-2030 Method breakdown estimates & forecasts, 2020-2030 Sample Type breakdown estimates & forecasts, 2020-2030 Application breakdown estimates & forecasts, 2020-2030 End-user breakdown estimates & forecasts, 2020-2030
10.4.2. Canada Cystatin C Assay Market
10.5. Europe Cystatin C Assay Market Snapshot
10.5.1. U.K. Cystatin C Assay Market
10.5.2. Germany Cystatin C Assay Market
10.5.3. France Cystatin C Assay Market
10.5.4. Spain Cystatin C Assay Market
10.5.5. Italy Cystatin C Assay Market
10.5.6. Rest of Europe Cystatin C Assay Market
10.6. Asia-Pacific Cystatin C Assay Market Snapshot
10.6.1. China Cystatin C Assay Market
10.6.2. India Cystatin C Assay Market
10.6.3. Japan Cystatin C Assay Market
10.6.4. Australia Cystatin C Assay Market
10.6.5. South Korea Cystatin C Assay Market
10.6.6. Rest of Asia Pacific Cystatin C Assay Market
10.7. Latin America Cystatin C Assay Market Snapshot
10.7.1. Brazil Cystatin C Assay Market
10.7.2. Mexico Cystatin C Assay Market
10.8. Middle East & Africa Cystatin C Assay Market
10.8.1. Saudi Arabia Cystatin C Assay Market
10.8.2. South Africa Cystatin C Assay Market
10.8.3. Rest of Middle East & Africa Cystatin C Assay Market

Chapter 11. Competitive Intelligence
11.1. Key Company SWOT Analysis
11.1.1. Company 1
11.1.2. Company 2
11.1.3. Company 3
11.2. Top Market Strategies
11.3. Company Profiles
11.3.1. Abbott (US) Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
11.3.2. Roche Diagnostics Limited (Switzerland)
11.3.3. Siemens Healthineers AG(Germany)
11.3.4. Thermo Fisher Scientific Inc. (US)
11.3.5. Randox Laboratories Ltd. (UK)
11.3.6. DiaSys Diagnostic Systems GmbH (Germany)
11.3.7. Bio-Techne (US)
11.3.8. Gentian Diagnostics ASA (Norway)
11.3.9. Getein Biotech, Inc. (China)
11.3.10. Agilent Technologies, Inc. (US)
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now